Mau-Sørensen, M.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review

Grunnet, Mie, Mau-Sørensen, Morten, Brünner, Nils

Journal:

Scandinavian Journal of Gastroenterology

Year:

2013

Language:

english

File:

PDF, 189 KB

english, 2013

2

Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients

Grunnet, M., Christensen, I.J., Lassen, U., Jensen, L.H., Lydolph, M., Lund, I.K., Thurison, T., Høyer-Hansen, G., Mau-Sørensen, M.

Journal:

Clinical Biochemistry

Year:

2014

Language:

english

File:

PDF, 294 KB

english, 2014

3

Serum tumor markers in bile duct cancer – a review

Grunnet, M., Mau-Sørensen, M.

Journal:

Year:

2014

Language:

english

File:

PDF, 174 KB

english, 2014

4

A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers

Lassen, U. N., Meulendijks, D., Siu, L. L., Karanikas, V., Mau-Sorensen, M., Schellens, J. H. M., Jonker, D. J., Hansen, A. R., Simcox, M. E., Schostack, K. J., Bottino, D., Zhong, H., Roessler, M., V

Journal:

Clinical Cancer Research

Year:

2015

Language:

english

File:

PDF, 1.07 MB

english, 2015

5

TOP1 gene copy numbers are increased in cancers of the bile duct and pancreas

Grunnet, Mie, Calatayud, Dan, Schultz, Nicolai Aa, Hasselby, Jane P., Mau-Sørensen, Morten, Brünner, Nils, Stenvang, Jan

Journal:

Scandinavian Journal of Gastroenterology

Year:

2015

Language:

english

File:

PDF, 516 KB

english, 2015

6

A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3

Mau-Sørensen, Morten, Dittrich, Christian, Dienstmann, Rodrigo, Lassen, Ulrik, Büchler, Wilfried, Martinius, Holger, Tabernero, Josep

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2015

Language:

english

File:

PDF, 308 KB

english, 2015

7

The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2

Alanin, Mikkel Christian, Klausen, Camilla, Caye-Thomasen, Per, Thomsen, Carsten, Fugleholm, Kaare, Poulsgaard, Lars, Lassen, Ulrik, Mau-Sorensen, Morten, Hofland, Kenneth Francis

Journal:

European Archives of Oto-Rhino-Laryngology

Year:

2015

Language:

english

File:

PDF, 180 KB

english, 2015

8

Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours

Plummer, Ruth, Swaisland, Helen, Leunen, Karin, van Herpen, Carla M. L., Jerusalem, Guy, De Grève, Jacques, Lolkema, Martijn P., Soetekouw, Patricia, Mau-Sørensen, Morten, Nielsen, Dorte, Spicer, Jame

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2015

Language:

english

File:

PDF, 488 KB

english, 2015

9

Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 – a retrospective case series

Alanin, Mikkel Christian, Klausen, Camilla, Caye-Thomasen, Per, Thomsen, Carsten, Fugleholm, Kaare, Poulsgaard, Lars, Lassen, Ulrik, Mau-Sorensen, Morten, Hofland, Kenneth Francis

Journal:

International Journal of Neuroscience

Year:

2015

Language:

english

File:

PDF, 519 KB

english, 2015

10

Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors

Meulendijks, D., Lassen, U. N., Siu, L. L., Huitema, A. D. R., Karanikas, V., Mau-Sorensen, M., Jonker, D. J., Hansen, A. R., Simcox, M. E., Schostack, K. J., Bottino, D., Zhong, H., Roessler, M., Veg

Journal:

Clinical Cancer Research

Year:

2015

Language:

english

File:

PDF, 963 KB

english, 2015

11

Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma

Lassen, U., Chinot, O. L., McBain, C., Mau-Sorensen, M., Larsen, V. A., Barrie, M., Roth, P., Krieter, O., Wang, K., Habben, K., Tessier, J., Lahr, A., Weller, M.

Journal:

Year:

2015

Language:

english

File:

PDF, 467 KB

english, 2015

12

PD-0022 * DECLINE IN CA19-9 DURING CHEMOTHERAPY PREDICTS SURVIVAL IN FOUR INDEPENDENT COHORTS OF PATIENTS WITH INOPERABLE CHOLANGIOCARCINOMA.

Grunnet, M., Christensen, I., Lassen, U., Jensen, L. H., Lydolph, M., Knox, J., McNamara, M., Jital, M., Wasan, H., Bridgewater, J., Valle, J., Mau-Sorensen, M.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 29 KB

english, 2014

13

505 Clinical evidence of intra-tumoral immune activation and tumor targeting with RG, a CEA-targeted engineered IL-2 immunocytokine

Tabernero, J., Homicsko, K., Schellens, J.H., Hoekstra, O., Van der Veen, L., Melero, I., és, G. Argil, Mau-Sorensen, M., Angevin, E., Joensuu, H., Van Brummelen, E., van Oordt, C.W. Menke-van der Hou

Journal:

European Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 75 KB

english, 2015

14

A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma

Hansson, M., Gimsing, P., Badros, A., Niskanen, T. M., Nahi, H., Offner, F., Salomo, M., Sonesson, E., Mau-Sorensen, M., Stenberg, Y., Sundberg, A., Teige, I., Van Droogenbroeck, J., Wichert, S., Zang

Journal:

Clinical Cancer Research

Year:

2015

Language:

english

File:

PDF, 273 KB

english, 2015

15

Clopidogrel paclitaxel drug-drug interaction: A pharmacoepidemiologic study

Agergaard, K., Mau-Sørensen, M., Stage, T.B., Jørgensen, T.L., Hassel, R.E., Steffensen, K.D., Pedersen, J.W., Milo, M.L.H., Poulsen, S.H., Pottegård, A., Hallas, J., Brøsen, K., Bergmann, T.K.

Journal:

Clinical Pharmacology & Therapeutics

Year:

2017

Language:

english

File:

PDF, 810 KB

english, 2017

16

Three-year follow-up of implementation of evidence-based transfusion practice in a tertiary hospital

Norgaard, A., Stensballe, J., de Lichtenberg, T. H., White, J. O., Perner, A., Wanscher, M., Hillingsø, J., Holm, M. L., Mau-Sørensen, M., Sillesen, H., Kjeldsen, L., Bäck, C., Nielsen, J., Seeberg, J

Journal:

Year:

2017

Language:

english

File:

PDF, 371 KB

english, 2017

17

A phase I clinical trial of single-agent selinexor in acute myeloid leukemia

Garzon, Ramiro, Savona, Michael, Baz, Rachid, Andreeff, Michael, Gabrail, Nashat, Gutierrez, Martin, Savoie, Lynn, Mau-Sorensen, Morten, Wagner-Johnston, Nina, Yee, Karen, Unger, T.J., Saint-Martin, J

Journal:

Year:

2017

Language:

english

File:

PDF, 604 KB

english, 2017

18

Detection of copy number alterations in cell-free tumor DNA from plasma

Østrup, Olga, Ahlborn, Lise Barlebo, Lassen, Ulrik, Mau-Sørensen, Morten, Nielsen, Finn Cilius

Journal:

Year:

2017

Language:

english

File:

PDF, 939 KB

english, 2017

19

Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin's lymphoma

Kuruvilla, John, Savona, Michael, Baz, Rachid, Mau-Sorensen, Morten, Gabrail, Nashat, Garzon, Ramiro, Stone, Richard, Wang, Michael, Savoie, Lynn, Martin, Peter, Flinn, Ian, Jacoby, Meagan, Unger, T.J

Journal:

Year:

2017

Language:

english

File:

PDF, 219 KB

english, 2017

20

Phase Ib study of lumretuzumab plus cetuximab or erlotinib in solid tumor patients and evaluation of HER3 and heregulin as potential biomarkers of clinical activity

Meulendijks, Didier, Jacob, Wolfgang, Voest, Emile E., Mau-Sørensen, Morten, Martinez-Garcia, Maria, Taus, Alvaro, Fleitas, Tania, Cervantes, Andres, Lolkema, Martijn, Langenberg, Marlies HG, de Jonge

Journal:

Clinical Cancer Research

Year:

2017

Language:

english

File:

PDF, 767 KB

english, 2017

21

Randomised feasibility study of a more liberal haemoglobin trigger for red blood cell transfusion compared to standard practice in anaemic cancer patients treated with chemotherapy

Yakymenko, D., Frandsen, K. B., Christensen, I. J., Norgaard, A., Johansson, P. I., Daugaard, G., Mau-Sorensen, M.

Journal:

Transfusion Medicine

Year:

2017

Language:

english

File:

PDF, 358 KB

english, 2017

22

New Drug Interaction: Clopidogrel Associated with Paclitaxel Induced Neuropathy in Cancer Patients

Bergmann, T.K., Agergaard, K., Mau-Sørensen, M., Stage, T.B., Jørgensen, T.L., Hassel, R.E., Steffensen, K.D., Pedersen, J.W., Milo, M.L.H., Poulsen, S.H., Pottegård, A., Hallas, J., Brosen, K.

Journal:

Clinical Therapeutics

Year:

2017

Language:

english

File:

PDF, 64 KB

english, 2017

23

Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers

Vergote, I., Lund, B., Havsteen, H., Ujmajuridze, Z., Van Nieuwenhuysen, E., Haslund, C., Juhler-Nøttrup, T., Neven, P., Mau-Sørensen, M., Berteloot, P., Kranich, A., Rashal, T., Meade, J., Landesman,

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 41 KB

english, 2016

24

Circulating tumor cell number predicts time to progression (TTP) in patients with heavily pretreated gynecological cancers treated with selinexor (SEL)

Crochiere, M., Vergote, I.B., Lund, B., Havsteen, H., Ujmajuridze, Z., Nieuwenhuysen, E. Van, Haslund, C., Juhler-Nøttrup, T., Mau-Sørensen, M., Berteloot, P., Kranich, A., Meade, J., Wright, G., Shac

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 39 KB

english, 2016

25

Patient information in phase I trials: A systematic review

Gad, Katrine Toubro, Lassen, Ulrik, Mau-Sørensen, Morten, Høybye, Mette Terp, Johansen, Christoffer

Journal:

Psycho-Oncology

Year:

2017

Language:

english

File:

PDF, 843 KB

english, 2017

26

supportive careInfluence of concomitant clopidogrel consumption on development of paclitaxel-associated toxicity: A pharmacoepidemiological study

Agergaard, K., Mau-Sørensen, M., Stage, T.B., Jørgensen, T.L., Hassel, R.E., Steffensen, K.D., Pedersen, J.W., Milo, M.L.H., Poulsen, S.H., Pottegård, A., Hallas, J., Brøsen, K., Bergmann, T.K.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 35 KB

english, 2016

27

1184PA phase I/II safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors

Chenard-Poirier, M., Hong, D.S., Coleman, R., de Bono, J., Mau-Sorensen, M., Collins, D., Lisby, S., Basse, L., Lassen, U.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 50 KB

english, 2017

28

OS07.5 Interim analysis data from Phase 2 study on efficacy, safety & intratumoral pharmacokinetics of oral Selinexor (KPT-330) in patients with recurrent glioblastoma (GBM)

Lassman, A. B., Bent, M. J. V. D., Wen, P. Y., Walenkamp, A., Plotkin, S., Kung, A., Gardner, H., Shacham, S., Chudnovsky, A., Mau-Sorensen, P. M.

Journal:

Year:

2017

Language:

english

File:

PDF, 84 KB

english, 2017

29

1845PSafety, clinical activity and pharmacological biomarker evaluation of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814: Results from two phase I trials

Mau-Sorensen, M, van Bussel, M, Kuipers, M, Nielsen, D L, Verheul, H M, Aftimos, P, de Jonge, M J A, van Triest, B, Falkenius, J, Debus, J, Troost, E, Samuels, M, Sarholz, B, Budach, V, Goel, S, Locat

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 76 KB

english, 2018

30

A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24

Mirza, Mansoor Raza, Bergmann, Troels K., Mau-Sørensen, Morten, Christensen, René dePont, Åvall-Lundqvist, Elisabeth, Birrer, Michael J., Jørgensen, Morten, Roed, Henrik, Malander, Susanne, Nielsen, F

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2019

Language:

english

File:

PDF, 675 KB

english, 2019

31

994PDCLINICAL ACTIVITY OF THE ORAL SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) SELINEXOR (KPT-330) IN PATIENTS WITH HEAD & NECK SQUAMOS CELL CARCINOMA (HN-SCC)

Mahipal, A., Gabrail, N.Y., Sukari, A., Mahaseth, H., Mau-Sorensen, M., Shacham, S., Saint-Martin, J., Friedlander, S., Landesman, Y., Ellis, J., Shacham, E., McCartney, J., Marshall, T., Vincent, D.,

Journal:

Annals of Oncology

Year:

2014

File:

PDF, 64 KB

2014

32

Copenhagen prospective personalized oncology (CoPPO): Genomic profiling to select patients for phase 1 trials

Tuxen, I.V., Yde, C.W., Mau-Sørensen, M., Santoni-Rugiu, E., Lassen, U., Nielsen, F.C.

Journal:

Annals of Oncology

Year:

2016

File:

PDF, 63 KB

2016

33

OA02.05 First-In-Human Phase 1/2 Trial of Anti-AXL Antibody–Drug Conjugate (ADC) Enapotamab Vedotin (EnaV) in Advanced NSCLC

Ramalingam, S., Lopez, J., Mau-Sorensen, M., Thistlethwaite, F., Piha-Paul, S., Gadgeel, S., Drew, Y., Jänne, P., Mansfield, A., Chen, G., Forssmann, U., Johannsdottir, H., Pencheva, N., Ervin-Haynes,

Journal:

Journal of Thoracic Oncology

Year:

2019

Language:

english

File:

PDF, 124 KB

english, 2019

34

OA02.05 First-In-Human Phase 1/2 Trial of Anti-AXL Antibody–Drug Conjugate (ADC) Enapotamab Vedotin (EnaV) in Advanced NSCLC

Ramalingam, S., Lopez, J., Mau-Sorensen, M., Thistlethwaite, F., Piha-Paul, S., Gadgeel, S., Drew, Y., Jänne, P., Mansfield, A., Chen, G., Forssmann, U., Johannsdottir, H., Pencheva, N., Ervin-Haynes,

Journal:

Journal of Thoracic Oncology

Year:

2019

File:

PDF, 124 KB

2019

35

Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies

Vergote, I.B., Lund, B., Peen, U., Umajuridze, Z., Mau-Sorensen, M., Kranich, A., Van Nieuwenhuysen, E., Haslund, C., Nottrup, T., Han, S.N., Concin, N., Unger, T.J., Chai, Y., Au, N., Rashal, T., Jos

Journal:

Gynecologic Oncology

Year:

2019

File:

PDF, 892 KB

2019